Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine |
I Care I Cure, The Brian Morden Foundation |
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine |
I Care I Cure, The Brian Morden Foundation |
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |